Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli
- 1 March 1980
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 17 (3) , 488-493
- https://doi.org/10.1128/aac.17.3.488
Abstract
This study compares the minimum inhibitory concentrations of cefoperazone, cefotaxime, and moxalactam (LY127935) for 446 aerobic gram-negative bacillary isolates and further compares the minimum inhibitory concentrations of LY127935 and these third-generation cephalosporins with those of thienamycin for Pseudomonas aeruginosa. Each antibiotic at low concentrations inhibited nearly all Enterobacteriaceae tested. Minimum inhibitory concentrations for P. aeruginosa were higher, but for a majority of strains they fell below achievable serum levels. Thienamycin and cefoperazone showed significantly greater antipseudomonal activity than did cefotaxime or LY127935. Cefoxitin-inducible resistance to LY127935 and the two cephalosporins was demonstrated among Enterobacter species but did not occur with thienamycin.This publication has 9 references indexed in Scilit:
- Diffusion Disk Susceptibility Testing with CefotaximeAntimicrobial Agents and Chemotherapy, 1979
- Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine CephalosporinAntimicrobial Agents and Chemotherapy, 1979
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- Antibacterial Activity of a New Parenteral Cephalosporin—HR 756: Comparison with Cefamandole and CeforanideAntimicrobial Agents and Chemotherapy, 1979
- In Vitro Activity of Cefotaxime Against Cephalothin-Resistant Clinical IsolatesAntimicrobial Agents and Chemotherapy, 1979
- Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-LactamasesAntimicrobial Agents and Chemotherapy, 1979
- Dissociated Resistance Among CephalosporinsAntimicrobial Agents and Chemotherapy, 1979
- Thienamycin: New Beta-Lactam Antibiotic with Potent Broad-Spectrum ActivityAntimicrobial Agents and Chemotherapy, 1979
- HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1979